HY-123593-1mL
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-18346-10mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
HY-18346-100mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
HY-18346-5mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
HY-18346-50mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
HY-18346-1mL
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
sc-300241
|
Santa Cruz Biotechnology
|
[Bis(trifluoromethanesulfonyl)imidate](triphenylphosphine)gold(I) (2:1) toluene adduct [CAS 866395-16-6]
|
|
|
|
sc-230247
|
Santa Cruz Biotechnology
|
2-Dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl gold(I) bis(trifluoromethanesulfonyl)imide [CAS 934506-10-2]
|
|
|
|
sc-252581
|
Santa Cruz Biotechnology
|
Chloro [(1,1'-biphenyl-2-yl)di-tert-butylphosphine]gold(I) [CAS 854045-93-5]
|
|
|
|
sc-300355
|
Santa Cruz Biotechnology
|
Chloro [1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene]gold(I)
|
|
|
|
sc-252582
|
Santa Cruz Biotechnology
|
Chloro [1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]gold(I) [CAS 852445-83-1]
|
|
|
|
sc-234322
|
Santa Cruz Biotechnology
|
Chloro [2-dicyclohexyl(2',4',6'-trisopropylbiphenyl)phosphine]gold(I) [CAS 854045-94-6]
|
|
|
|
sc-239510
|
Santa Cruz Biotechnology
|
Chloro(triphenylphosphine)gold(I) [CAS 14243-64-2]
|
|
|
|
sc-234579
|
Santa Cruz Biotechnology
|
Dichloro(2-pyridinecarboxylato)gold [CAS 88215-41-2]
|
|
|
|
sc-300770
|
Santa Cruz Biotechnology
|
Gold Platinum Palladium powder, APS 2-5 micron [CAS 127330-90-9]
|
|
|
|
sc-300770A
|
Santa Cruz Biotechnology
|
Gold Platinum Palladium powder, APS 2-5 micron [CAS 127330-90-9]
|
|
|
|
sc-228264
|
Santa Cruz Biotechnology
|
Gold(I) iodide [CAS 10294-31-2]
|
|
|
|
sc-269224
|
Santa Cruz Biotechnology
|
Gold(III) hydroxide, Au 79% min [CAS 1303-52-2]
|
|
|
|